Rarezot schreef op 9 maart 2020 08:23:
I know nobody asked me, but I did a financial analysis on my own based on the year results of Biocartis. And right now, I value the company at about 9€/share. I know that is quite conservative compared to other analysts, but it still means that the company right now is extremely undervalued.
I do have a breakdown of the results, but since it hard to explain an entire spreadsheet in a post on here, I decided to post it on youtube. (
youtu.be/NuEuEmO-nVQ ).
I only use publicly known information. So FL, you don't have to be afraid of an 'investor notification' and to be honest I would really appreciate your opinion (I don't mind being proven wrong) :)
Rarezot